Ribasphere FDA Approval History
FDA Approved: Yes (First approved April 6, 2004)
Brand name: Ribasphere
Generic name: ribavirin
Dosage form: Capsules
Company: Three Rivers Pharmaceuticals, LLC
Treatment for: Hepatitis C
Ribasphere (ribavirin) is a nucleoside analogue indicated in combination with peginterferon alfa-2a for the treatment of adults with chronic hepatitis C virus infection.
Development Timeline for Ribasphere
|Apr 7, 2004||Ribasphere Three Rivers Pharmaceuticals - Treatment for Hepatitis C ("HCV")|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.